Transfection Technologies Market Size, Share, Growth Analysis, by Product (Kits, Equipment), By Method (Physical, Biochemical), By Application (Biomedical Research, Therapeutic Delivery), By End User, By Region - Industry Forecast 2024-2031

The market in North America is expected to grow significantly, driven by factors such as increasing prevalence of cancer and other chronic diseases, increasing use of vectors, which require vector-borne pathways body to treat chronic diseases. Rising cancer burden in the US. among people is one of the major drivers of the market. For example, according to American Cancer Society data released in March 2022, the total number of new cancer cases in 2022 is estimated to be 2 million. Among cancer patients, breast cancer is expected to increase the incidence of penile cancer. Transfection technology is widely used in cancer therapy, which is believed to drive the growth of the studied market in the US.

The APAC region dominated the market. Increasing investments in research programs, biopharmaceutical development, and academic collaborations are driving demand for transfection technologies in the region. APAC countries are emerging as an important market for gene therapy research and development. With high patient densities, high healthcare costs, and supportive regulatory frameworks, these countries provide important opportunities for companies involved in transformational technologies. APAC has become a manufacturing hub for biopharmaceuticals and related technologies. Companies in this segment manufacture transfection reagents, devices and consumables catering to both domestic and international markets. Several MNCs form collaborations and strategic partnerships with academic institutions, research organizations and biotechnology companies in the APAC region.